Fortune Brands Innovations, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Fortune Brands Innovations, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	4,985	5,283	5,485	5,765	6,090	7,656	4,723	4,626	4,609	4,463
Cost of revenue	3,189	3,358	3,526	3,712	2,157	2,841	2,790	2,715	2,543	2,474
Gross profit	1,805	1,925	1,959	2,052	2,164	4,816	1,933	1,911	2,066	1,989
Research and development	53.1	50.7	50.3	48.2
Selling, general and administrative	1,136	1,197	1,241	1,256	849	1,094	1,078	1,168	1,239	1,292
Operating income	619	683	595	699	568	811	774	615	738	516
Interest expense	49.1	49.4	74.5	94.2	83.8	84.3	119	117	121	115
Other non-operating income	12.6	1.7	16.3	-29	15.3	-0.4	12	19.5	-11.9	4.1
Pre-tax income	582	635	537	575	499	726	667	518	606	405
Income tax	170	160	147	144	111	167	127	112	134	106
Income from continuing operations	412	475	390	432	553
Net income to minority interests		0.1	0.2	-0.6	1.3	0	0
Net income	413	473	390	432	553	772	687	405	472	299
EBITDA	713	781	709	810	689	936	901	722	858	635
EPS, basic	2.68	3.08	2.69	3.09	3.99	5.62	5.27	3.19	3.78	2.48
EPS, diluted	2.62	3.03	2.66	3.06	3.94	5.54	5.23	3.17	3.75	2.47
Shares, basic (weighted)	154	153	145	140	139	138	130	127	125	121
Shares, diluted (weighted)	158	156	146	141	140	140	131	128	126	121
Dividend per share	0.66	0.74	0.82	0.90	0.98	1.06	1.07	0.93	0.97	1.01

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	252	323	263	388	419	426	643	366	381	264
Receivables	551	555	572	625	735	580	522	534	514	513
Inventory	531	581	679	719	867	890	1,021	982	960	1,025
Other current assets	112	143	173	167	187	135	275	163	152	172
Total current assets	1,445	1,602	1,686	1,898	2,209	2,745	2,460	2,046	2,007	1,974
Property, plant and equipment	663	740	813	824	917	671	784	975	999	806
Lease right-of-use assets				166	170	131	119	174	148	260
Goodwill	1,834	1,912	2,080	2,090	1,469	1,539	1,641	1,907	1,992	2,006
Intangible assets	1,107	1,162	1,247	1,169	1,420	968	1,001	1,355	1,297	1,232
Other non-current assets	80	95.3	138	144	248	108	116	109	115	129
Total assets	5,129	5,511	5,965	6,291	7,359	5,447	6,121	6,565	6,562	6,521
Accounts payable	394	429	459	460	621	561	422	568	514	525
Accrued liabilities	449	106	85.9	110	167	132	57.6	125	114	57.2
Short-term debt	0	0	525	400		400	599	0	500	0
Total current liabilities	843	907	1,492	1,409	1,345	1,971	1,545	1,200	1,602	1,072
Long-term debt	1,431	1,508	1,809	1,785	2,572	2,310	2,074	2,670	2,174	2,545
Lease liabilities				140	141	109	95.4	143	122	244
Other non-current liabilities	112	153	158	171	205	170	103	99.2	92.3	102
Total liabilities	2,766	2,910	3,785	3,864	4,583	4,871	4,034	4,272	4,140	4,132
Total debt	1,431	1,508	2,334	2,184	2,572	2,710	2,674	2,670	2,673	2,545
Paid-in capital	2,654	2,725	2,766	2,814	2,926	3,018	3,070	3,135	3,189	3,214
Retained earnings	815	1,174	1,448	1,763	2,180	2,808	2,324	2,605	2,957	3,135
Treasury stock	-1,037	-1,262	-1,971	-2,079	-2,278	-2,739	-3,346	-3,512	-3,768	-4,027
Other comprehensive income	-71.9	-39.2	-67	-72.6	-55.1	-24.6	37.4	63.3	42.4	64.2
Shareholders' equity	2,362	2,600	2,178	2,427	2,776
Minority interests	1.5	1.6	1.8	1.2
Total equity	2,363	2,601	2,180	2,428	2,776	3,065	2,087	2,293	2,422	2,389
Total liabilities and equity	5,129	5,511	5,965	6,291	7,359	7,936	6,121	6,565	6,562	6,521
Shares outstanding	153	152	140	140	139	135	128	126	124	120

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	413	473	390	431	554	772	687	405	472	299
Depreciation and amortization	94.6	98.6	114	111	122	125	127	107	121	119
Stock-based compensation	32	43	36.1	30.5	47.6	50.2	50.2	34.2	39.3	20.8
Deferred income tax	-25.8	-18.7	2.8	-7.5	-14.6	1.7	14.8	-26.1	0.2	32.3
Change in receivables	-39.1	1	9.8	-50.7	-85.7	-152	66.3	25.7	6.3	5.6
Change in inventory	52.4	-24.8	-55	-38.3	-91.8	-324	-199	149	16.6	-55.4
Change in payables	57.6	24	21	8.7	143	138	-161	101	-29.3	9.5
Cash from operations	651	600	604	637	826	689	566	1,056	668	479
Capital expenditures	-149	-165	-150	-132	-151	-214	-246	-257	-193	-112
Acquisitions	-240	-125	-466		-715	5.2	-218	-784	-135	0
Purchases of investments			-28.7		-59.4
Cash from investing	-385	-288	-634	-128	-924	-207	-456	-1,038	-303	-105
Debt issued	1,065	640	2,191	1,719	1,850	1,245	5,975	1,065	915	1,920
Debt repaid	-805	-565	-1,890	-1,345	-1,465	-1,510	-5,613	-470	-915	-1,550
Stock issued	25.5	28.5	4.9	17.3	64.9	41.8	1.1	18	15.5	4.5
Share buybacks	-425	-215	-695	-100	-188	-448	-580	-150	-240	-248
Dividends paid	-98.2	-110	-115	-123	-133	-143	-146	-117	-120	-121
Cash from financing	-250	-250	-6.8	-390	112	-429	72.5	-271	-363	-503
Exchange rate effect	-2	9	-15.2	4.3	16.3	-1.9	-11.1	0.5	-11.5	11.5
Net change in cash	13	71.5	-52.3	124	30.1	51.1	172	-253	-10	-118
Free cash flow	501	435	454	505	675	475	320	799	475	367
Interest paid	43.7	44.4	63.4	81	76.2	76.8	103	121	127	123
Income taxes paid	-0.6	170	114	145	176	229	278	120	152	79

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $39.38 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	45.9%	Gross profit / revenue.
Operating margin	6.8%	Operating income / revenue.
EBITDA margin	9.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	4.2%	Pre-tax income / revenue.
Net margin	3.4%	Net income / revenue.
FCF margin	9.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	11.3%	Cash from operations / revenue.
Effective tax rate	19.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)	2.3%	Net income / average total assets.
SG&A / revenue	30.4%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.2%	Capital expenditures / revenue.
D&A / revenue	2.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-3.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-1.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-6.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-3.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	1.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-1.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-30.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-12.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-1.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-26.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-11.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-1.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-36.7%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-24.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-11.6%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-34.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-22.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-8.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-28.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-5.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-10.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-22.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	4.6%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-11.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	4.1%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-1.9%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	0.6%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-0.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	2.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-3.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-2.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.01x	Current assets / current liabilities.
Quick ratio	0.79x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.20x	(Cash + short-term investments) / current liabilities.
Debt / assets	40.2%	Total debt / total assets.
Liabilities / assets	63.6%	Total liabilities / total assets.
Net debt	$2.34B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	5.85x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.73x	Operating income / interest expense.
Working capital	$1.04B	Current assets - current liabilities.
Goodwill and intangibles / assets	49.1%	(Goodwill + intangible assets) / total assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.69x	Revenue / average total assets.
Fixed asset turnover	6.76x	Revenue / average property, plant and equipment.
Inventory turnover	2.40x	Cost of revenue / average inventory.
Days inventory	152 days	365 x average inventory / cost of revenue.
Receivables turnover	7.23x	Revenue / average receivables.
Days sales outstanding	50 days	365 x average receivables / revenue.
Days payables	80 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	123 days	Days inventory + days sales outstanding - days payables.
FCF conversion	269.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	19.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.25	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$36.81	Revenue / diluted weighted shares.
FCF per share	$3.36	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.16	Cash from operations / diluted weighted shares.
Cash per share	$1.76	(Cash + short-term investments) / shares outstanding.
Payout ratio	82.1%	Dividends paid / net income, when net income is positive.
Dividends / FCF	30.5%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	13.8%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$4.70B	Share price x shares outstanding.
Enterprise value	$7.04B	Market cap + total debt - cash - short-term investments.
P/E	31.6x	Market cap / net income. Only when net income is positive.
P/S	1.07x	Market cap / revenue.
P/FCF	11.7x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	9.47x	Market cap / cash from operations, when positive.
EV/Sales	1.60x	Enterprise value / revenue.
EV/EBIT	23.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	17.6x	Enterprise value / EBITDA, when both are positive.
EV/FCF	17.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	8.5%	Free cash flow / market cap.
Earnings yield	3.2%	Net income / market cap (the inverse of P/E).
Dividend yield	2.6%	Dividends paid over the period / market cap.
Shareholder yield	3.8%	(Dividends paid + share buybacks) / market cap.

What was Fortune Brands Innovations, Inc.'s revenue in fiscal 2025?

Fortune Brands Innovations, Inc. reported revenue of $4.46B for fiscal 2025, 3.2% lower than the year before.

Was Fortune Brands Innovations, Inc. profitable in fiscal 2025?

Yes. Net income was $298.8M, a net margin of 6.7%.

How much free cash flow did Fortune Brands Innovations, Inc. generate in fiscal 2025?

Cash from operations of $478.6M minus capital expenditures of $111.8M left free cash flow of $366.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Fortune Brands Innovations, Inc.